Literature DB >> 35303805

Assessment of the prevalence and associated risk factors of pediatric hydrocephalus in diagnostic centers in Addis Ababa, Ethiopia.

Blein Mulugeta1, Girma Seyoum2, Abebe Mekonnen3, Elbet Ketema4.   

Abstract

BACKGROUND: Hydrocephalus (HCP) is a common disorder of cerebral spinal fluid (CSF) physiology resulting in abnormal expansion of the cerebral ventricles. Infants commonly present with progressive macrocephaly whereas children older than 2 years generally present with signs and symptoms of intracranial hypertension. Neither qualitatively nor quantitatively are there adequate data to determine the prevalence and incidence of HCP in the developing world. HCP is a treatable condition that when left untreated, has fatal consequences.
OBJECTIVE: The objective of this study was to assess the prevalence of pediatric HCP and associated risk factors in diagnostic centers in Addis Ababa, Ethiopia.
METHODS: This study was conducted using a cross-sectional facility-based study design over a two-time period, i.e. a 2-year retrospective data collection from January 2018 to January 2020 included 1101 patients and a prospective data collection from May 2019 to February 2020 included 99 patients. Children aged 5 years and below who came to the selected diagnostic centers for MRI/CT examination were studied. The collected data were analyzed using binary logistic regression. RESULT: The retrospective study included 639(58%) males and 462 (42%) females. The mean age calculated was 22.3 months. Infants aged younger than 24 months 753 (68.4%) were significantly associated with HCP development (P < 0.05). In the retrospective study, HCP etiologies; Aqueductal stenosis (17.9%), Neural Tube defects (NTDs) (35.7%), post-infectious (10.1%) were identified. In the prospective study, the gender and age distribution was 57(57.6%) males, 42 (42.4%) females, 60.6% infants aged younger than 24 months with a mean age of 24.9 months. Inadequate consumption of folic acid and development of HCP was found to be statistically significant (P < 0.05). In the prospective study, HCP etiologies; Aqueductal stenosis (26.1%), Neural Tube defects (26.08%), and post-infectious (8.69%) were identified. The 3 years prevalence of HCP calculated in both studies was 22% (223 per 1000 live births).
CONCLUSION: The results of this study suggest that the high prevalence of HCP was due to the high prevalence of aqueductal stenosis and neural tube defects; with a small contribution of post-infectious causes. The majority of infants who present with HCP were aged younger than 24 months.
© 2022. The Author(s).

Entities:  

Keywords:  CT; Cerebrospinal fluid; Hydrocephalus; MRI and neural tube defects

Mesh:

Year:  2022        PMID: 35303805      PMCID: PMC8932009          DOI: 10.1186/s12887-022-03212-6

Source DB:  PubMed          Journal:  BMC Pediatr        ISSN: 1471-2431            Impact factor:   2.125


Background

Hydrocephalus (HCP) is defined as a pathophysiology with disturbed cerebrospinal fluid (CSF) circulation [1]. Infants commonly present with progressive macrocephaly whereas children older than 2 years generally present with signs and symptoms of intracranial hypertension [2]. In the developed world, the incidence of congenital HCP has been estimated to be about 0.5 cases per 1000 live births and the overall incidence of neonatal HCP is estimated to be about 3 to 5 cases per 1000 live births [3]. Neither qualitatively nor quantitatively are there any adequate data/literature to determine the prevalence and incidence of HCP in the developing world, especially in sub-Saharan Africa, where this condition appears to be much more frequent than in developed countries. Taking some very conservative estimates in Uganda, as an example, between 1000 and 2000 new cases of infant HCP occurs every year, with this most likely being an underestimate. Extrapolating this to other regions suggests 6500 new cases per year in East Africa and more than 45,000 new cases per year in sub-Saharan Africa [4]. HCP is a common neurosurgical disorder that can lead to significant disability or death if not promptly identified and treated. Data on the burden of HCP in low-income countries are limited, given a lack of radiologic resources for the diagnosis of this condition [5]. In Ethiopia, the etiology and incidence rates of HCP can be assumed to correspond to what has been reported from other East African countries, where HCP has been estimated to have an infectious origin. Only a minute fraction of children with HCP in Ethiopia – a few hundred each year - are diagnosed and receive proper treatment for their HCP. This probably means a selection bias that makes it difficult or even impossible to determine or estimate the general characteristics of HCP in Ethiopia concerning etiology, type of HCP, gender, or age composition of the patients. If the estimates on new cases of pediatric HCP in Ethiopia are valid, these children represent an enormous challenge for the nation [6]. HCP has many causes. Congenital HCP, most commonly involving aqueduct stenosis, and HCP can also be acquired, mostly from pathological processes that affect subarachnoid space function [2]. Continued research and education are essential if a significant reduction in morbidity and mortality from this disease is to be accomplished [4]. Hence, this study has assessed the prevalence and possible risk factors of pediatric HCP from a large sample of CT and MRI scans of the head performed at selected diagnostic centers in Addis Ababa, Ethiopia, a low-income country in Africa. The findings of this study will give focus on the management of HCP, and will create awareness for the importance of prenatal care given to mothers during their pregnancy.

Methods and materials

This study was performed in four of the diagnostic centers that work in close association with Addis Ababa University, Wudassie Diagnostic Center (WDC), Dr. Alia Diagnostic Center, Pioneer Diagnostic Center, and BMY Diagnostic Center; all chosen randomly. This study was conducted from January 2018 to February 2020. A cross-sectional facility-based study was conducted over a two-time period, i.e. a 2-year retrospective data collection from January 2018 to January 2020 and a prospective data collection from May 2019 to February 2020. The study design involved children aged 5 years and below who came to the diagnostic centers for MRI/CT examination during the data collection periods. The retrospective data collection included 1101 patients and the prospective data collection included 99 patients. All children of either gender aged 5 years and below sent for Brain MRI /CT examination were included in the study. Patients, who had surgery for HCP before the study period started, patients who had imaging examinations besides the Brain, and parents/caretakers not willing to participate in the study were excluded. The retrospective data were collected by the employment of a checklist that included the patient’s clinical indication, the type of modality used, confirmation of HCP, and type of HCP confirmed. The prospective data were collected through a pre-tested semi-structured questionnaire that consisted of socio-demographic and economic factors, maternal conditions, and radiological results of the study participants. The data were entered, cleaned, and analyzed using SPSS software version 23.0. The data collected was analyzed by descriptive analysis. The 3 years prevalence of HCP was calculated in both the retrospective and prospective studies as the total included patients per 1000 live births). Bivariate analysis, using crudes odds ratio (COR), was used to test the degree of association between dependent and independent variables. Those variables that were identified to have a P-value less than 0.2 were included in the multivariate analysis, using adjusted odds ratio (AOR), to identify predictors of the outcome variable in the prospective study. These variables were; age, prenatal care, folic acid supplementation, family history of HCP, educational level of the mother, maternal pathologies, and infections. In the retrospective study, only multivariate analysis was applied because of the limited amount of variables. This was due to a lack of patient charts in diagnostic centers resulting in fewer clinical data. Both studies used a 95% confidence interval (CI) with a P-value of less than 0.05 taken as statistically significant. Ethical clearance was obtained from the Anatomy Department, College of Health Sciences, and the office of diagnostic centers. The purpose and importance of the study were explained to each study participant and they were informed that no personal identifiers were used in the data. Verbal and written consent was also obtained from each participant. Participants had the right to be excluded from the study if they were not voluntary to participate.

Results

Characteristics of study participants

In the retrospective study, a total of 1101 children under 5 years of age participated. Of these, 639(58%) were males and 462(42%) were females. The mean age and standard deviations were 22.3 months and ± 18.8 respectively. There were 753 (68.4%) children aged younger than 24 months. The number of children diagnosed with HCP during the retrospective study was 245 (22.3%), of these HCP cases, 153(62.4%) were classified as non-communicating HCP. The proportion of males diagnosed with HCP was relatively higher. Table 1.
Table 1

Characteristics of Study Participants of the Retrospective Study within the Selected Diagnostic Centers in Addis Ababa, Ethiopia, 2018-2020

VariableCategoryFrequencyPercent (%)
Age of child≤24 months75368.4
GenderMale63958
Female46242
Type of modality usedMRI73666.8
HCP diagnosed casesYes24522.3
HCP TypeNon-communicating15362.4
HCP diagnosed casesIn males14057.14
Characteristics of Study Participants of the Retrospective Study within the Selected Diagnostic Centers in Addis Ababa, Ethiopia, 2018-2020 Similarly, children under 5 years of age were included in the prospective data with a mean age of 24.9 months and a standard deviation of ±19.2. Of a total of 99 children, 57 (57.6%) were males and 42(42.4%) were females. Ninety-three (93.9) were imaged using MRI. This data set had 60 (60.6%) children aged younger than 24 months. Of the number of children diagnosed with HCP 23 (23.2%); 13(56.5%) were classified as non-communicating HCP. The proportion of females diagnosed with HCP was relatively higher in this study Table 2. The history of HCP among families was found to account for 46 (46.5%) of all the interviewed cases. Also, it was identified that 55.6% of the families had a first-degree relative. Regarding the maternal history, occupational and educational status are all described in Table 2.
Table 2

Characteristics of Study Participants of the Prospective Study within the Selected Diagnostic Centers in Addis Ababa, Ethiopia, 2019-2020

VariablesCategoryFrequencyPercent (%)
Age of child≤24 months6060.6
HCP diagnosed casesYes2323.2
HCP TypeNon-communicating1356.5
HCP diagnosed casesIn females1257.12
Age of mother18-232323.7
24-294546.4
29-341717.5
35-401212.4
Did not attend school2224.2
The educational level of the motherElementary school(1-8)2931.9
High school(9-12)2224.2
Diploma and above1819.8
Occupational status of the motherEmployed1718.7
Housewife7481.3
Type of modality usedMRI9393.9
Residential areaUrban5050.5
Rural4949.5
Antenatal care follow upYes7582.4
Mode of deliveryCesarean1920.9
Vaginal7178
Trauma during pregnancyYes88.8
Pre-eclampsiaYes99.9
Sexually transmitted diseaseYes44.4
Diabetes mellitusYes22.2
Uterine infectionYes99.9
Folic acid supplementYes6167.8
Usage of folic acidBefore conceiving33.3
After conceiving5858.6
History of HCPYes4646.5
Family relativesFirst degree555.6
Second degree222.2
Third degree222.2
Characteristics of Study Participants of the Prospective Study within the Selected Diagnostic Centers in Addis Ababa, Ethiopia, 2019-2020

Prevalence of HCP

The number of children diagnosed with HCP in the 3 years in both retrospective and prospective studies was 22.3% i.e. 222.72 per 1000 births (2222.72 per 10,000 births).

Prevalence of congenital and acquired HCP

Prevalence of congenital and acquired HCP in both study periods was studied based on MRI and CT images, of all children diagnosed with HCP (22.3%). Congenital HCP secondary to Aqudectal stenosis, 17.6 and 26.1% in the retrospective and prospective study respectively, was identified to be the most prevalent. (Fig. 1). Neural tube defects (NTDs) were identified as the second most prevalent cause. Chari II malformation and Dandy-Walker variant account for the majority of NTDs identified in the retrospective and prospective study respectively. (Tables 3 and 4). Acquired HCP secondary to post-infectious, post-hemorrhagic, and tumor-related causes was identified. Post-infectious, 10.2 and 8.69% identified in retrospective and prospective periods respectively was attributed to post-meningitis complications and chronic in-utero infection (TORCH- Toxoplasmosis, Rubella, Cytomegalovirus, and Herpes), Ventriculitis, Cerebral and Cerebellar abscess (Tables 3 and 4).
Fig. 1

Brain MRI of a 4 months old male infant. Clinical indication: Hydrocephalus. Description: Sagittal T2, Axial fast spin echo (FSE T2), and Coronal Fluid attenuation inversion recovery (FLAIR) sequences performed on a 1.5 T MR scanner revealed grossly dilated lateral and third ventricles with posterior fossa cyst communicating with the fourth ventricle inferiorly and hypoplastic cerebellar vermis. The cerebellar hemispheres are also small and displaced anteriorly. The surrounding cerebral parenchyma is thinned out. The major intracranial arterial and venous flow-voids are patent. The visualized portions of the paranasal sinuses and orbits are unremarkable. IMPRESSION: Hydrocephalus with posterior fossa cyst and cerebellar vermis hypoplasia likely Dandy-Walker malformation

Table 3

Congenital and Acquired Pediatric HCP- Retrospective data compilation from the Selected Diagnostic Centers in Addis Ababa, Ethiopia, 2018-2020

Congenital and Acquired HCPn%
Aqueductal Stenosis4417.9
Chari II malformation4116.7
Dandy-Walker Malformation2811.4
Colpocephaly83.2
Encephalocele52.04
Myelomeningocele20.81
Meningoencephalocele31.2
Post-infectious83.2
Post-meningitis176.9
Adhesion of Foramen of Monroe10.4
Medulloblastoma124.8
Pineal gland glioma10.4
Ependymoma10.4
Craniopharyngioma20.8
Subdural Hematoma10.4
Hypoxic-ischemic cerebral injury31.2
Perinatal ischemic insult31.2
Cystic Encephalomalacia20.8
Dural venous malformation10.4
Table 4

Prevalence of Congenital and Acquired Pediatric HCP- Prospective data compilation from the Selected Diagnostic Centers in Addis Ababa, Ethiopia, 2019-2020

Congenital and Acquired Pediatric HCPn%
Aqueductal Stenosis626.1
Dandy-Walker malformation417.4
Chari II Malformation28.7
Meningocele28.69
Meningoencephalocele28.69
Post-meningitis28.69
Medulloblastoma28.69
Germinoma28.69
Craniopharyngioma28.69
Subdural Hematoma521.7
Ex-vacuo ventriculomegaly due to Post-perinatal hypoxic-ischemic cerebral injury521.7
Ex-vacuo ventriculomegaly due to perinatal hypoxic-ischemic cerebral injury313.04
Brain MRI of a 4 months old male infant. Clinical indication: Hydrocephalus. Description: Sagittal T2, Axial fast spin echo (FSE T2), and Coronal Fluid attenuation inversion recovery (FLAIR) sequences performed on a 1.5 T MR scanner revealed grossly dilated lateral and third ventricles with posterior fossa cyst communicating with the fourth ventricle inferiorly and hypoplastic cerebellar vermis. The cerebellar hemispheres are also small and displaced anteriorly. The surrounding cerebral parenchyma is thinned out. The major intracranial arterial and venous flow-voids are patent. The visualized portions of the paranasal sinuses and orbits are unremarkable. IMPRESSION: Hydrocephalus with posterior fossa cyst and cerebellar vermis hypoplasia likely Dandy-Walker malformation Congenital and Acquired Pediatric HCP- Retrospective data compilation from the Selected Diagnostic Centers in Addis Ababa, Ethiopia, 2018-2020 Prevalence of Congenital and Acquired Pediatric HCP- Prospective data compilation from the Selected Diagnostic Centers in Addis Ababa, Ethiopia, 2019-2020

Risk factors associated with HCP

The retrospective study found that those children aged under 24 months diagnosed with HCP 192(78.3%) had a 1.9 times higher risk of developing HCP than those aged above 24 months which was found to be statistically significant; (AOR = 1.90 [95% CI = 1.36, 2.26], P < 0.05). Table 5.
Table 5

Associated Risk factors of HCP of the Retrospective Data within the Selected Diagnostic Centers in Addis Ababa, Ethiopia, 2018-2020

VariablesCategoryDiagnosisCOR (CI 95%)AOR (CI 95%)P-value
YesNo
Age of the child≤24 months1925591.89 (1.36, 2.65)*1.90 (1.36, 2.26)*0.000

Note: *significance; p < 0.05

Associated Risk factors of HCP of the Retrospective Data within the Selected Diagnostic Centers in Addis Ababa, Ethiopia, 2018-2020 Note: *significance; p < 0.05 In the prospective study, the number of children aged under 24 months diagnosed with HCP was 15 (65.2%). Even though this accounted for the majority of the HCP patients, it was not statistically significant (P > 0.05). Gender also was not significantly associated with the presence of HCP (P > 0.05). Table 6. Mothers who did not take folic acid nutritional supplements 29 (32.8%) were identified to be significantly associated with HCP occurrence (AOR = 6.107 [95% CI = 1.32, 28.35], P < 0.05) Table 6. This study identified that interviewed mothers who had Pre-eclampsia were (9.9%), chronic hypertension (8.8%), and Diabetes mellitus (2.2%) during their gestation as potential risk factors but a significant association with HCP was not found (P > 0.05). No association (P > 0.05) was found with regards to advanced maternal age, family history of HCP, sexually transmitted infections, alcohol, and cigarette smoking among interviewed mothers. (Table 6).
Table 6

Associated Risk factors of HCP of the Prospective data within the Selected Diagnostic Centers in Addis Ababa, Ethiopia, 2019-2020

VariablesCategoryDiagnosisCOR (CI 95%)AOR (CI 95%)P-value
YesNo
Age of child≥24 months83111
≤24 months15451.2(0.08 -1.3)1.3 (0.6- 1.7)0.606
GenderMale114611
Female12300.59(0.23- 1.52)1.69 (0.63- 4.54)0.283
Age of mother18-2322111
24-2914310.21(0.04- 1.03)0.22 (0.04- 1.08)0.054
29-345120.23 (0.038- 1.36)0.24 (0.04- 1.43)0.105
35-402100.48(0.06-3.88)0.43 (0.05- 3.58)0.489
The educational level of the motherDid not attend school81411
Elementary school(1-8)6232.2(0.63-7.64)2.04 (0.54- 7.79)0.219
High school(9-12)4182.6(0.64-10.31)2.61 (0.57- 11.7)0.183
Diploma and above3152.8(0.63- 12.9)3.92 (0.78- 19.5)0.174
Antenatal care attendanceYes195611
No2142.38(0.49- 11.41)0.34 (0.06- 1.78)0.280
Consumption of folic acidYes194211
No2276.107(1.32- 28.35)*1.64 (0.052- 51.5)*0.021*
Use of folic acidBefore conceiving2111
After conceiving17410.59(0.04-0.804)0.27 (0.009- 8.32)0.036*
History of HCP in the familyYes172911
No6474.52 (1.624- 12.984)*4.89 (0.64- 3.23)*0.907
Trauma to the mother during pregnancyYes4411
No17663.882(0.88-17.140)2.93 (0.56- 15.3)0.073

Note: *significance; P < 0.05

Associated Risk factors of HCP of the Prospective data within the Selected Diagnostic Centers in Addis Ababa, Ethiopia, 2019-2020 Note: *significance; P < 0.05

Discussions

Demographics: sex and age

As opposed to their female counterparts, males had a relatively higher chance of being diagnosed with HCP. This finding is similar to published studies in other African countries which have shown that the majority of pediatric patients with HCP are males; 64.6% of the population in a study from Tanzania and 53% in a study from Kenya [7]; 60.5% in a study from Nigeria [8], as well as a predominance of 51.9% in a study from Uganda [9], and 66.7% in another study in Ethiopia [6]. However, the prospective study had a different finding; as it was found that females had a relatively higher chance of being diagnosed with HCP. In this study, sex was not considered as one of the risk factors of HCP. As a result, the relatively higher prevalence of HCP among males in the retrospective study and females in the prospective study was not further investigated. In this study, there was a slight increment in the mean age of pediatric patients from 22.3 months in the retrospective study to 24.9 months in the prospective study but the difference was not statistically significant. A significant association between age and the development of HCP was found in the retrospective study, as children aged younger than 24 months had a higher risk of developing HCP similar to other published articles [10, 11]. Non-communicating HCP (obstructive HCP) predominance has been attributed to Aqueductal stenosis and NTDs in agreement with a similarly conducted Ethiopian study [6].

Prevalence and etiologies of HCP

In developed countries, the incidence of congenital HCP is estimated at three to five cases per 1000 live births [3]. Contrary to this, the prevalence of HCP in this study in the 3 years was 22% (223 per 1000 live births) higher than prevalence rates seen in four European regions [12], Denmark [13], California [14], northern China [15], and prevalence in a Nigerian region [16]. However, the results of this study are in agreement with the study conducted in Uganda-from CURE Children’s Hospital of Uganda (CCHU) which demonstrated infant HCP prevalence rate between 1000 and 2000 cases every year [4]. This study is also similar to research conducted here in Addis Ababa, which used the estimates applied in the Ugandan research and presented an estimate of between 2000 and 4000 new cases of pediatric HCP per year [6]. In presenting the causes and incidence rates of HCP from Uganda [4], Tanzania [17], and Kenya [18] where it served as a reference for Ethiopia, there is a contradiction concerning the cause of HCP as a small contribution of post-infectious causes was found in this study. This discrepancy may be explained by differences in methodology. In the Ugandan study, for example, post-infectious HCP (PIH) was defined in terms of the absence of HCP at birth, history of febrile illness or seizure, and evidence of prior ventriculitis [4]. In this study, however, post-natal imaging investigations were studied thus defining PIH in terms of post-natal diagnosis. As described earlier, the high prevalence rate of HCP in this study has been attributed to high percentages of Aqueductal stenosis and NTDs similar to studies conducted in Zambia, Zimbabwe, and Malawi [19]. This study has also found HCP associated with meningomyelocele (MMC) similar to studies in Uganda [4], Kenya [18], Tanzania [17], south-western Saudi Arabia [20], and another Ethiopian study [6].

The risk factors associated with pediatric HCP

It has been suggested that getting adequate prenatal care might help prevent birth defects, HCP being one of them [21]. Although an association between prenatal care given to mothers and HCP development was expected, this study did not find this to be significant, similar to a study from Mississippi [22]. It was initially hypothesized that mothers who attend their prenatal follow-ups would be aware of the use of folic acid thus avoiding NTDs that lead to HCP. This may be explained by the low literacy rate of female adults in Ethiopia that affects mothers’ ability to navigate the health care system. As previously predicted, due to the inadequate consumption of folic acid supplements this study has found NTDs that lead to HCP. This finding, that is, the association of taking folic acid nutritional supplements and the development of HCP is interesting considering the clear relationship between folic acid deficiency and the development of NTDs. This is similar to the study from Nigeria that suggested the high incidence of NTDs was due to the lack of use of folic acid by the majority of the mothers of the affected children [16]. Similar studies have suggested the consumption of adequate amounts of folic acid by women before pregnancy and during early pregnancy decreases their risk for having a pregnancy affected by NTDs [23], and a study in Northern China that found the supplementation of folic acid reduced the incidence of HCP and NTDs [15]. An association between advanced maternal age and the development of HCP was not found similar to a study in Mississippi [22]. An increased risk of having a child with HCP among young mothers has been reported [21], however, this study was not designed to determine the mechanism by which birth defects occur among different age groups of mothers. Further investigation is needed to understand the effects of maternal age on HCP and other birth defects. Although this study found additional family members, especially first-degree relatives with HCP similar to studies in Mississippi [22] and Denmark [24], it did not find any association. Familial aggregation and both the genetic and maternal effects play important roles in congenital HCP pathogenesis. However, this study did not investigate genetics as a risk factor for HCP due to the lack of genetic laboratories and clinics; further exploration is recommended. The lack of association in the above variables may be due to limited sample size, constrained resources at the time of data collection while conducting the prospective study, and lack of patient’s clinical data that reduced the number of study variables in the retrospective study.

Strengths and limitations of the study

The strength of this study was; cross-sectional facility-based study design employed across the four selected diagnostic centers allowed this study to be representative of the study population and the limitation of this study was; the limited amount of time and resource the prospective study had and failure of the MRI machine during this data collection period, as a result, has decreased the total studied population.

Conclusions

The high prevalence of pediatric HCP observed in both study periods was due to Aqueductal stenosis followed by NTDs with minimal contribution from infectious causes and post-traumatic complications. Non-communicating HCP was the most predominant type of HCP. Infants aged younger than 24 months were a major risk factor in the development of HCP. There is a high association between the amount of folic acid consumption in early pregnancy and the incidence of NTDs which leads to developing HCP. The majority of HCP diagnosed patients had first-degree relatives with congenital HCP.

Recommendations

It would be ideal if public teaching hospitals affiliated with universities, public and private medical schools, and diagnostic centers across the country conducted similar research regarding the prevalence and risk factors of HCP. This would help in formulating a guideline that can be used across the nation and better understand its public health impact. Further investigation is recommended to understand maternal risk factors associated with the occurrence of congenital and acquired HCP. If a centrally managed database of patients’ clinical history among public and private health institutes was organized under the Ministry of Health, it would help keep records for better management of the patient and will also serve as a medical and public health policy input.
  19 in total

1.  Time trends and demographics of deaths from congenital hydrocephalus in children in the United States: National Center for Health Statistics data, 1979 to 1998.

Authors:  John H Chi; Heather J Fullerton; Nalin Gupta
Journal:  J Neurosurg       Date:  2005-08       Impact factor: 5.115

2.  Management of infantile hydrocephalus in Central Africa.

Authors:  A Adeloye
Journal:  Trop Doct       Date:  2001-04       Impact factor: 0.731

3.  Effectiveness of the Bactiseal Universal Shunt for reducing shunt infection in a sub-Saharan African context: a retrospective cohort study in 160 Ugandan children.

Authors:  Jordan D Lane; John Mugamba; Peter Ssenyonga; Benjamin C Warf
Journal:  J Neurosurg Pediatr       Date:  2013-12-06       Impact factor: 2.375

Review 4.  Quantifying the effect of folic acid.

Authors:  N J Wald; M R Law; J K Morris; D S Wald
Journal:  Lancet       Date:  2001-12-15       Impact factor: 79.321

5.  Outcomes of ventriculoperitoneal shunt insertion in Sub-Saharan Africa.

Authors:  Esther Gathura; Dan Poenaru; Richard Bransford; A Leland Albright
Journal:  J Neurosurg Pediatr       Date:  2010-10       Impact factor: 2.375

6.  Pediatric Hydrocephalus in Ethiopia: Treatment Failures and Infections: A Hospital-Based, Retrospective Study.

Authors:  Tsegazeab Laeke; Abenezer Tirsit; Hagos Biluts; Deeptha Murali; Knut Wester
Journal:  World Neurosurg       Date:  2017-01-03       Impact factor: 2.104

Review 7.  Treatment of cerebrospinal fluid shunting complications in a Nigerian neurosurgery programme. Case illustrations and review.

Authors:  Edward O Komolafe; Augustine A Adeolu; Morenikeji A Komolafe
Journal:  Pediatr Neurosurg       Date:  2007-12-14       Impact factor: 1.162

8.  Maternal age and non-chromosomal birth defects, Atlanta--1968-2000: teenager or thirty-something, who is at risk?

Authors:  Jennita Reefhuis; Margaret A Honein
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2004-09

9.  Infant hydrocephalus in sub-Saharan Africa: the reality on the Tanzanian side of the lake.

Authors:  Maria M Santos; Derick K Rubagumya; Imani Dominic; Amos Brighton; Soledad Colombe; Philip O'Donnell; Micaella R Zubkov; Roger Härtl
Journal:  J Neurosurg Pediatr       Date:  2017-09-08       Impact factor: 2.375

10.  Risk factors of congenital hydrocephalus: a 10 year retrospective study.

Authors:  M Van Landingham; T V Nguyen; A Roberts; A D Parent; J Zhang
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-07-24       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.